Erica Warlick is an Oncology physician. OpenAlex indexes 189 publications with 4,601 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
420 Delaware St SE
Mmc 480
Minneapolis, MN 554550341
Telephone
612-624-0123Registry record last updated 12 Jul 2007.
Clinical trials
- Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
Sponsor: Masonic Cancer Center, University of Minnesota
- Allo HSCT Using RIC for Hematological Diseases
Sponsor: Masonic Cancer Center, University of Minnesota
- Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
Sponsor: Masonic Cancer Center, University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.3%Azole Antifungal8%Fluconazole68%Voriconazole32%Part D<11 patientsShort-acting sulfonamides7.1%Sulfamethoxazole-Trimethoprim100%Part D≥12 patients+ 5 more classes in this area
Dermatology
16.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16.8%Acyclovir100%Part D≥29 patientsNervous system
14.6%SSRI4.4%Citalopram Hbr54%Sertraline Hcl46%Part D<11 patientsSNRI2.7%Duloxetine Hcl100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”